Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada
ConclusionThis real-world data collection illustrates an increasing use of “out-of-trial” innovative therapies in pediatric oncology. This new field of practice warrants further studies to understand the impact on patient trajectory and equity in access to innovative therapies.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Sandra Judd,
Gabriel Revon ‐Riviere,
Stephanie A. Grover,
Rebecca J. Deyell,
Magimairajan Issai Vanan,
Victor A. Lewis,
Lucie Pecheux,
Alexandra P. Zorzi,
Catherine Goudie,
Raoul Santiago,
Thai Hoa Tran,
Lesleigh S. Abbott,
Josee Brossard,
Tags: RESEARCH ARTICLE Source Type: research
More News: Brain | Canada Health | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Insurance | Leukemia | Lymphoma | Neurology | Pediatrics | Study